| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |